Add BrightSurf on Google Email

University of California - Los Angeles


Drug that cuts off tumor's blood supply extends lives of colorectal cancer patients

Researchers found that combining Avastin with chemotherapy improves median survival, reduces risk of death and increases response rates in patients with advanced colorectal cancer. The study showed a nearly five-month improvement in patient survival, demonstrating the potential of targeting tumor blood supply as a viable treatment option.

SourceUniversity of California - Los Angeles·JournalNew England Journal of Medicine·DateJun 2, 2004

UCLA study shows Medicaid costs can shrink

A UCLA study found that providing Head Start parents with easy-to-understand health-care guidance can lead to significant reductions in emergency room and clinic visits, resulting in cost savings for Medicaid. The study showed a 48% reduction in unnecessary ER visits and a 37.5% decrease in clinic visits for routine illnesses.

SourceUniversity of California - Los Angeles·JournalJournal of Community Health·DateApr 15, 2004

UCLA research explores biology of fear

Researchers at UCLA have made a groundbreaking discovery about the biology of fear, finding that yohimbine accelerates the process of overcoming conditioned fear in mice. By enhancing the effects of natural adrenaline release, yohimbine allows mice to overcome their fear four times faster than those treated with vehicle or propanolol.

SourceUniversity of California - Los Angeles·JournalLearning & Memory·DateApr 1, 2004

Shyness can be deadly

A study by UCLA researchers found that individuals with shy personalities tend to have higher viral loads and faster disease progression, even on antiretroviral therapy. This suggests that high-stress individuals may be more susceptible to HIV replication due to their heightened nervous system response.

SourceUniversity of California - Los Angeles·JournalBiological Psychiatry·DateDec 15, 2003

UCLA-led study challenges bipolar depression treatment guidelines

A UCLA-led study found that individuals with bipolar depression who continued taking antidepressants in conjunction with mood stabilizer medication after remission had a lower risk of depression relapse. The study's lead author, Dr. Lori Altshuler, suggests guidelines similar to those for unipolar depression may be more effective.

SourceUniversity of California - Los Angeles·JournalAmerican Journal of Psychiatry·DateJul 1, 2003